Please join Kate Sasser, Senior Vice President, Head of Translational Research and R&D Operations, and Hisham Hamadeh, Vice President and Global Head of Data Science at Genmab, as they discuss how Genmab’s scientists bridge two different but related worlds—translational research and data science—with the hope to deliver the right cancer therapy for the right patient using Genmab’s proprietary antibody platform.